ALBUMIN CONTENT IN BRAIN AND CSF AFTER INTRACAROTID INFUSION OF PROTAMINE SULFATE - A LONGITUDINAL-STUDY

被引:16
作者
WESTERGREN, I
JOHANSSON, BB
机构
[1] Department of Neurology, Lund University, Lund
关键词
D O I
10.1016/0014-4886(90)90158-O
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The endogenous serum albumin content was determined by immunoelectrophoresis in brain and cisternal CSF 1, 24, and 72 h after a transient opening of the blood-brain barrier. Protamine sulfate, 5 mg in 100 μl 0.9% NaCl, was infused during 30 s into the internal carotid artery via a catheter in the external carotid artery in conscious rats. The albumin content in CSF was 0.08 ± 0.03 g/liter before protamine infusion and 0.09 ± 0.02 g/liter in rats infused with saline only. The levels were significantly increased one and 24 h after protamine infusion (0.37 ± 0.19 and 0.23 ± 0.09 g/liter, P < 0.001) but not at 72 h (0.14 ± 0.05 g/liter). The albumin content in the right (injected) hemisphere decreased with time but was significantly higher than that in the left hemisphere at all times (P < 0.001 1 and 24 h after protamine; P < 0.01 at 72 h). There was no correlation between the albumin contents in brain and CSF. Pretreatment with dixyrazine, a phenothiazine derivate, significantly reduced the protamine-induced leakage of endogenous serum albumin into brain and CSF. © 1990.
引用
收藏
页码:192 / 196
页数:5
相关论文
共 19 条
[1]   FACTORS INFLUENCING EXIT OF SUBSTANCES FROM CEREBROSPINAL-FLUID INTO DEEP CERVICAL LYMPH OF THE RABBIT [J].
BRADBURY, MWB ;
WESTROP, RJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1983, 339 (JUN) :519-534
[2]   HEMODYNAMIC-CHANGES IN BRAIN CAUSED BY LOCAL INFUSION OF HYPER-OSMOLAR SOLUTIONS, IN PARTICULAR RELATION TO BLOOD-BRAIN-BARRIER OPENING [J].
HARDEBO, JE ;
NILSSON, B .
BRAIN RESEARCH, 1980, 181 (01) :49-59
[3]   ENDOTHELIAL NEGATIVE SURFACE-CHARGE AREAS AND BLOOD-BRAIN BARRIER FUNCTION [J].
HARDEBO, JE ;
KAHRSTROM, J .
ACTA PHYSIOLOGICA SCANDINAVICA, 1985, 125 (03) :495-499
[4]  
JEZOVA D, 1989, NEUROENDOCRINOLOGY, V49, P428
[5]  
Johanson C. E., 1989, IMPLICATIONS BLOOD B, V1, P223
[6]  
Johansson B B, 1986, Acta Neurochir Suppl (Wien), V36, P137
[7]  
JOHANSSON BB, 1981, ACTA PHARMACOL TOX, V48, P242
[8]  
JOHANSSON BB, 1982, STROKE, V66, P220
[10]  
MURPHY VA, 1985, J CEREBR BLOOD F MET, V5, P401, DOI 10.1038/jcbfm.1985.55